“alzheimers”的搜索结果，显示 81-90 项，共有 5598 项

1. 神经科- 临床试验- 妙佑医疗国际

   A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease. Scottsdale ...

2. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

4. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...

6. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

7. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

8. 神经科- 临床试验- 妙佑医疗国际

   A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease. Scottsdale ...

9. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

10. 神经科- 临床试验- 妙佑医疗国际

    Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...